AI isn’t close to curing cancer. This startup says it knows what it will take. | TechCrunch
A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a…
A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a…
Park Koo-sun, Chairman of the Daegu-Gyeongbuk Medical Innovation Foundation. Photo courtesy of K-MEDI hub “Once the Medical Technology Training Institute…
Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off…